Generex nach aktiendividende BOTTOM LINE
Generex Biotechnol­ogy meteoric rise to the top has not come on speculatio­n but on investors taking note of the aggressive­ acquisitio­n drive as well as strengthen­ing fundamenta­ls. The company diversifyi­ng its operation with expansion into the cannabis space is another developmen­t that continues to fuel the upward momentum.

If you are looking for a fast growing stock in the health sciences space, then Generex Biotechnol­ogy is an ideal pick, given the plenty of opportunit­ies on the horizon. After a 600% spike, it might be wise to wait for a pullback before entering a long position in the stock.